Difficulty: Medium
Average Score: 63%
Practice
Indicate a cholinomimetic agent, which is related to direct-acting drugs:
Correct answer
C
Rationale
In the context of pharmacological lifespan treatment, understanding cholinomimetic agents is crucial. In this case, the correct answer is C) Carbachol. Carbachol is a direct-acting cholinomimetic agent that directly stimulates cholinergic receptors, mimicking the actions of acetylcholine. It is used in the treatment of conditions like glaucoma and postoperative urinary retention.
Now, let's analyze why the other options are incorrect:
A) Edrophonium: Edrophonium is an indirect-acting cholinomimetic agent that inhibits acetylcholinesterase temporarily, leading to an increase in acetylcholine levels. It is used in the diagnosis of myasthenia gravis.
B) Physostigmine: Physostigmine is also an indirect-acting cholinomimetic agent that inhibits acetylcholinesterase. It is used in the treatment of anticholinergic toxicity.
D) Isoflurophate: Isoflurophate is an irreversible acetylcholinesterase inhibitor used in the treatment of glaucoma.
Understanding the differences between direct-acting and indirect-acting cholinomimetic agents is essential for healthcare professionals to effectively manage various conditions across the lifespan. It is important to grasp the specific mechanisms of action of different drugs to make informed decisions in clinical practice.
Now, let's analyze why the other options are incorrect:
A) Edrophonium: Edrophonium is an indirect-acting cholinomimetic agent that inhibits acetylcholinesterase temporarily, leading to an increase in acetylcholine levels. It is used in the diagnosis of myasthenia gravis.
B) Physostigmine: Physostigmine is also an indirect-acting cholinomimetic agent that inhibits acetylcholinesterase. It is used in the treatment of anticholinergic toxicity.
D) Isoflurophate: Isoflurophate is an irreversible acetylcholinesterase inhibitor used in the treatment of glaucoma.
Understanding the differences between direct-acting and indirect-acting cholinomimetic agents is essential for healthcare professionals to effectively manage various conditions across the lifespan. It is important to grasp the specific mechanisms of action of different drugs to make informed decisions in clinical practice.